This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Brevibloc

Baxter International Inc.

Drug Names(s): Esmolol

Description: Brevibloc is a beta 1-selective (cardioselective) blocking agent with a short duration of action (elimination half-life of approximately 9 minutes). Beta blockers block the action of epinephrine and norepinephrine. As a result, they slow the heart rate, and slow conduction through the AV node between the atria (upper chambers) and ventricles (lower chambers) of the heart.


Brevibloc News

Pink Sheet BOC Health Care


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug